For pharmaceutical manufacturers, CROs, research organizations, and testing laboratories, this guide provides the complete analytical testing framework for semaglutide across all three formulations from drug substance characterization through bioanalytical method development, injectable safety testing, stability, and immunogenicity
The most common side effects are mild and may include nausea, stomach discomfort, constipation, diarrhea, bloating, or fatigue
GLP-1 agonists do not typically alter thyroid hormone levels in patients with normal thyroid function, though TSH may decrease with weight loss
Lorenzo Leggio told CNN last year
The angiotensin IV derivative is of interest to researchers because of its unique affinity for hepatocyte growth factor (HGF) signaling pathways
The central nervous system effects help explain why patients sometimes report mood and appetite changes when starting or adjusting GLP-1 therapy